Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients

British Journal of Haematology

Volumn 118, Issue 3, 2002, Pages 893-898

  Atichartakarn, Vichai ^a   Angchaisuksiri, Pantep ^a   Aryurachai, Katcharin ^a   Onpun, Supornchai ^a   Chuncharunee, Suporn ^a   Thakkinstian, Ammarin ^a   Atamasirikul, Kanlayanee ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Haemoglobin E; Hypercoagulable state; Splenectomy; Thalassaemia

Indexed keywords

BIOLOGICAL MARKER; CELL MARKER; HEMOGLOBIN E; LIPOCORTIN 5; PHOSPHATIDYLSERINE; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ARTERY THROMBOSIS; ARTICLE; BETA THALASSEMIA; BLOOD CLOTTING TIME; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE MEMBRANE; ERYTHROCYTE VOLUME; FEMALE; HUMAN; HUMAN CELL; HYPERCOAGULABILITY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY ARTERY DISEASE; RISK FACTOR; SPLENECTOMY;

ADULT; ANTITHROMBIN III; BETA-THALASSEMIA; CHRONIC DISEASE; ERYTHROCYTES; FEMALE; HEMOGLOBIN E; HUMANS; MALE; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PHOSPHATIDYLSERINES; PROTHROMBIN; SPLENECTOMY; THROMBOPHILIA;

EID: 0036039730     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03711.x     Document Type: Article

References (26)

1. Pulmonary hypertension and right heart failure in patients with β-thalassaemia intermedia
2. Platelet hyperaggregation in patients with β-thalassemia/Hb E disease: A consequence of splenectomy
3. Hemostatic and thrombotic markers in patients with β-thalassemia/Hb E disease
4. Increased erythrocyte phosphatidylserine exposure in sickle cell disease: Flow-cytometric measurement and clinical associations
5. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia
6. Levels of serum interleukin 6 and tumor necrosis factor in postsplenectomized thalassemic patients
7. Increased exposition of red cell phosphatidylserine (PS) may be a risk factor for thrombosis in splenectomized patients with hereditary stomatocytosis and pyruvate kinase deficiency
8. Recognition and destruction of neoplastic cells by activated macrophages. Discrimination of altered self
9. The measurement and interpretation of serum ferritin
10. Uncoupling of the membrane skeleton from lipid bilayers: The cause of accelerated phospholipid flip-flop leading to enhanced procoagulant activity of sickled cells
11. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassaemia
12. Quantitation of hemoglobin components by high performance cation exchange liquid chromatography
13. Membrane phospholipid asymmetry in human thalassemia
14. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia
15. The thalassemias and related disorders: Quantitative disorders of hemoglobin synthesis
16. The β-thalassemias
17. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay
18. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide
19. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
20. Pulmonary artery obstruction in thalassemia
21. Cardiac pathology in 76 thalassemic patients
22. Altered membrane phospholipid organization and erythrophagocytosis in E β-thalassaemia
23. Plasmodium falciparum: Effect of infected erythrocytes on clotting time of plasma
24. Hemoglobinopathies including thalassemia
25. Phosphatidylserine in the outer leaflet of red blood cells from β-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes
26. Induction of endothelial cell/macrophage procoagulant activity: Synergistic stimulation by gamma interferon and granulocyte-macrophage colony stimulating factor